ELV vs NBIX
Elevance Health vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | ELV | NBIX |
|---|---|---|
| AI Score | 53 | 66 |
| Price | $377.46 | $175.67 |
| P/E Ratio | 16.79× | 26.20× |
| ROE | 0.1% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.4% | 1.0% |
| Debt / Equity | 0.69× | 0.12× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 37.1 | 56.8 |
| Beta | 0.683 | 0.386 |
| Expected Upside | +1.4% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ELV Full Analysis
NBIX Full Analysis